APO RESEARCH · REPORT
Silk Fibroin (SF)
Silk fibroin is a nature biomaterial derived from cocoon and silk. Studies have found that silk fibroin have the advantages of green processing, excellent biocompatibility, high molecular weight, and tissue repair characteristic.
Product & engineering
Understand the product.
Silk fibroin is a nature biomaterial derived from cocoon and silk. Studies have found that silk fibroin have the advantages of green processing, excellent biocompatibility, high molecular weight, and tissue repair characteristic.
Selected research
Market Structure
Global Silk Fibroin (SF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Silk fibroin is a nature biomaterial derived from cocoon and silk. Studies have found that silk fibroin have the advantages of green processing, excellent biocompatibility, high molecular weight, and tissue repair characteristic.
On the basis of product type, Type of Silk Amino Acidsrepresent the largest share of the worldwide Silk Fibroin (SF) market, with 40% share. In the applications, Cosmetic & Personal Care segment is estimated to be the largest end-use industry segment of the market in 2019, with 71% share of global market. Asia Pacific holds the major share in the market, with a share of 60%.
This report provides an overview of the global Silk Fibroin (SF) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Silk Fibroin (SF) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Silk Fibroin (SF) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Silk Fibroin (SF) market size, projected growth trends, production technologies, key applications, and end-use industries.
Silk Fibroin (SF) Segment by Company
Huzhou Silkspark Bio-tech Co. Ltd
LANXESS
Hanzhou Linran
Huzhou Xintiansi Bio-tech
Chongqing Haifan Biochemical
Zhejiang Silk Seekers Biotechnology
Seidecosa
Suzhou Suhao Bio
Caresilk
Kelisema Srl
Silk Fibroin (SF) Segment by Type
Silk Fibroin Powder
Silk Amino Acids
Silk Peptide
Silk Fibroin (SF) Segment by Application
Cosmetic & Personal Care
Biomedical
Supplements
Silk Fibroin (SF) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Silk Fibroin (SF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Silk Fibroin (SF) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Silk Fibroin (SF).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Silk Fibroin (SF) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Silk Fibroin (SF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Silk Fibroin (SF) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Silk Fibroin (SF) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Silk Fibroin Powder
- Silk Amino Acids
- Silk Peptide
Applications
- Cosmetic & Personal Care
- Biomedical
- Supplements
Companies covered
- Huzhou Silkspark Bio-tech Co. Ltd
- LANXESS
- Hanzhou Linran
- Huzhou Xintiansi Bio-tech
- Chongqing Haifan Biochemical
- Zhejiang Silk Seekers Biotechnology
- Seidecosa
- Suzhou Suhao Bio
- Caresilk
- Kelisema Srl
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Silk Fibroin (SF) Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Silk Fibroin (SF) Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Silk Fibroin (SF) Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Silk Fibroin (SF) Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Silk Fibroin (SF) Market Dynamics
- 2.1 Silk Fibroin (SF) Industry Trends
- 2.2 Silk Fibroin (SF) Industry Drivers
- 2.3 Silk Fibroin (SF) Industry Opportunities and Challenges
- 2.4 Silk Fibroin (SF) Industry Restraints
3 Silk Fibroin (SF) Market by Manufacturers
- 3.1 Global Silk Fibroin (SF) Revenue by Manufacturers (2021-2026)
- 3.2 Global Silk Fibroin (SF) Sales by Manufacturers (2021-2026)
- 3.3 Global Silk Fibroin (SF) Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Silk Fibroin (SF) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Silk Fibroin (SF) Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Silk Fibroin (SF) Manufacturers, Product Type & Application
- 3.7 Global Silk Fibroin (SF) Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Silk Fibroin (SF) Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Silk Fibroin (SF) Players Market Share by Revenue in 2025
- 3.8.3 2025 Silk Fibroin (SF) Tier 1, Tier 2, and Tier 3
4 Silk Fibroin (SF) Market by Type
- 4.1 Silk Fibroin (SF) Type Introduction
- 4.1.1 Silk Fibroin Powder
- 4.1.2 Silk Amino Acids
- 4.1.3 Silk Peptide
- 4.2 Global Silk Fibroin (SF) Sales by Type
- 4.2.1 Global Silk Fibroin (SF) Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Silk Fibroin (SF) Sales by Type (2021-2032)
- 4.2.3 Global Silk Fibroin (SF) Sales Market Share by Type (2021-2032)
- 4.3 Global Silk Fibroin (SF) Revenue by Type
- 4.3.1 Global Silk Fibroin (SF) Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Silk Fibroin (SF) Revenue by Type (2021-2032)
- 4.3.3 Global Silk Fibroin (SF) Revenue Market Share by Type (2021-2032)
5 Silk Fibroin (SF) Market by Application
- 5.1 Silk Fibroin (SF) Application Introduction
- 5.1.1 Cosmetic & Personal Care
- 5.1.2 Biomedical
- 5.1.3 Supplements
- 5.2 Global Silk Fibroin (SF) Sales by Application
- 5.2.1 Global Silk Fibroin (SF) Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Silk Fibroin (SF) Sales by Application (2021-2032)
- 5.2.3 Global Silk Fibroin (SF) Sales Market Share by Application (2021-2032)
- 5.3 Global Silk Fibroin (SF) Revenue by Application
- 5.3.1 Global Silk Fibroin (SF) Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Silk Fibroin (SF) Revenue by Application (2021-2032)
- 5.3.3 Global Silk Fibroin (SF) Revenue Market Share by Application (2021-2032)
6 Global Silk Fibroin (SF) Sales by Region
- 6.1 Global Silk Fibroin (SF) Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Silk Fibroin (SF) Sales by Region (2021-2032)
- 6.2.1 Global Silk Fibroin (SF) Sales by Region (2021-2026)
- 6.2.2 Global Silk Fibroin (SF) Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Silk Fibroin (SF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Silk Fibroin (SF) Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Silk Fibroin (SF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Silk Fibroin (SF) Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Silk Fibroin (SF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Silk Fibroin (SF) Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Silk Fibroin (SF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Silk Fibroin (SF) Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Silk Fibroin (SF) Revenue by Region
- 7.1 Global Silk Fibroin (SF) Revenue by Region
- 7.1.1 Global Silk Fibroin (SF) Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Silk Fibroin (SF) Revenue by Region (2021-2026)
- 7.1.3 Global Silk Fibroin (SF) Revenue by Region (2027-2032)
- 7.1.4 Global Silk Fibroin (SF) Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Silk Fibroin (SF) Revenue (2021-2032)
- 7.2.2 North America Silk Fibroin (SF) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Silk Fibroin (SF) Revenue (2021-2032)
- 7.3.2 Europe Silk Fibroin (SF) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Silk Fibroin (SF) Revenue (2021-2032)
- 7.4.2 Asia-Pacific Silk Fibroin (SF) Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Silk Fibroin (SF) Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Silk Fibroin (SF) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Huzhou Silkspark Bio-tech Co. Ltd
- 8.1.1 Huzhou Silkspark Bio-tech Co. Ltd Company Information
- 8.1.2 Huzhou Silkspark Bio-tech Co. Ltd Business Overview
- 8.1.3 Huzhou Silkspark Bio-tech Co. Ltd Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Huzhou Silkspark Bio-tech Co. Ltd Silk Fibroin (SF) Product Portfolio
- 8.1.5 Huzhou Silkspark Bio-tech Co. Ltd Recent Developments
- 8.2 LANXESS
- 8.2.1 LANXESS Company Information
- 8.2.2 LANXESS Business Overview
- 8.2.3 LANXESS Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 LANXESS Silk Fibroin (SF) Product Portfolio
- 8.2.5 LANXESS Recent Developments
- 8.3 Hanzhou Linran
- 8.3.1 Hanzhou Linran Company Information
- 8.3.2 Hanzhou Linran Business Overview
- 8.3.3 Hanzhou Linran Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Hanzhou Linran Silk Fibroin (SF) Product Portfolio
- 8.3.5 Hanzhou Linran Recent Developments
- 8.4 Huzhou Xintiansi Bio-tech
- 8.4.1 Huzhou Xintiansi Bio-tech Company Information
- 8.4.2 Huzhou Xintiansi Bio-tech Business Overview
- 8.4.3 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Huzhou Xintiansi Bio-tech Silk Fibroin (SF) Product Portfolio
- 8.4.5 Huzhou Xintiansi Bio-tech Recent Developments
- 8.5 Chongqing Haifan Biochemical
- 8.5.1 Chongqing Haifan Biochemical Company Information
- 8.5.2 Chongqing Haifan Biochemical Business Overview
- 8.5.3 Chongqing Haifan Biochemical Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Chongqing Haifan Biochemical Silk Fibroin (SF) Product Portfolio
- 8.5.5 Chongqing Haifan Biochemical Recent Developments
- 8.6 Zhejiang Silk Seekers Biotechnology
- 8.6.1 Zhejiang Silk Seekers Biotechnology Company Information
- 8.6.2 Zhejiang Silk Seekers Biotechnology Business Overview
- 8.6.3 Zhejiang Silk Seekers Biotechnology Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Zhejiang Silk Seekers Biotechnology Silk Fibroin (SF) Product Portfolio
- 8.6.5 Zhejiang Silk Seekers Biotechnology Recent Developments
- 8.7 Seidecosa
- 8.7.1 Seidecosa Company Information
- 8.7.2 Seidecosa Business Overview
- 8.7.3 Seidecosa Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Seidecosa Silk Fibroin (SF) Product Portfolio
- 8.7.5 Seidecosa Recent Developments
- 8.8 Suzhou Suhao Bio
- 8.8.1 Suzhou Suhao Bio Company Information
- 8.8.2 Suzhou Suhao Bio Business Overview
- 8.8.3 Suzhou Suhao Bio Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Suzhou Suhao Bio Silk Fibroin (SF) Product Portfolio
- 8.8.5 Suzhou Suhao Bio Recent Developments
- 8.9 Caresilk
- 8.9.1 Caresilk Company Information
- 8.9.2 Caresilk Business Overview
- 8.9.3 Caresilk Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Caresilk Silk Fibroin (SF) Product Portfolio
- 8.9.5 Caresilk Recent Developments
- 8.10 Kelisema Srl
- 8.10.1 Kelisema Srl Company Information
- 8.10.2 Kelisema Srl Business Overview
- 8.10.3 Kelisema Srl Silk Fibroin (SF) Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Kelisema Srl Silk Fibroin (SF) Product Portfolio
- 8.10.5 Kelisema Srl Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Silk Fibroin (SF) Value Chain Analysis
- 9.1.1 Silk Fibroin (SF) Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Silk Fibroin (SF) Production Mode & Process
- 9.2 Silk Fibroin (SF) Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Silk Fibroin (SF) Distributors
- 9.2.3 Silk Fibroin (SF) Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst